| Sep 26, 2025 |
Sep 29, 2025 |
Aquestive Therapeutics, Inc.
|
CEO |
Sell |
26.3
|
-91,343
|
-9.00%
|
✓
|
$551.2K |
| Sep 19, 2025 |
Sep 22, 2025 |
Aquestive Therapeutics, Inc.
|
CEO |
Sell |
58.8
|
-400
|
-0.04%
|
✓
|
$2.4K |
| Mar 7, 2025 |
Mar 11, 2025 |
Aquestive Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+188,695
|
22.83%
|
✗
|
$220.8K |
| Mar 9, 2024 |
Oct 2, 2024 |
Aquestive Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-56,824
|
-6.43%
|
✗
|
$277.3K |
| Mar 9, 2024 |
Mar 12, 2024 |
Aquestive Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-37,938
|
-4.30%
|
✗
|
$185.1K |
| Jun 8, 2022 |
Jun 10, 2022 |
Aquestive Therapeutics, Inc.
|
CEO |
Buy |
95.0
|
+91,743
|
89.98%
|
✗
|
$88.1K |
| Aug 27, 2019 |
Aug 27, 2019 |
Aquestive Therapeutics, Inc.
|
COO |
Buy |
77.5
|
+2,000
|
2.00%
|
✗
|
$8K |
| Dec 10, 2018 |
Dec 10, 2018 |
Aquestive Therapeutics, Inc.
|
SVP-Chief Strategy/Dev Officer |
Buy |
77.5
|
+1,000
|
1.01%
|
✗
|
$8K |